https://openbell.ai/ 2026-09-25T18:54:45.932Z hourly 1.0 https://openbell.ai/support 2026-09-25T18:54:45.932Z monthly 0.7 https://openbell.ai/privacy 2026-09-25T18:54:45.932Z monthly 0.5 https://openbell.ai/terms 2026-09-25T18:54:45.932Z monthly 0.5 https://openbell.ai/feed.json 2026-09-25T18:54:45.932Z hourly 0.8 https://openbell.ai/news/INCY:1790362428234 2026-09-25T18:53:48.234Z daily 0.9 https://cdn.brandfetch.io/INCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Approves Atebrioz (Zilurgisertib) For Fibrodysplasia Ossificans Progressiva In Adults & Pediatric Patients 12+ Years; Atebrioz Recommended Dosage 100mg Once Daily The FDA has approved Atebrioz (Zilurgisertib) for the treatment of Fibrodysplasia Ossificans Progressiva in both adults and pediatric patients aged 12 years and older. The recommended dosage for this medication is 100mg once daily. This approval marks the third treatment option available for this rare condition, potentially impacting the market for INCY's stock. https://openbell.ai/news/NIVF:1790362085608 2026-09-25T18:48:05.608Z daily 0.9 https://cdn.brandfetch.io/NIVF/w/400/h/400?c=1idopYfmtR7ZKg8QMud NewGenIvf Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 66.54% openbell Financial News https://openbell.ai/news/MMM:1790362021751 2026-09-25T18:47:01.751Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Copenhagen--Denmark---August-3--2019-3m-.jpg?width=250&height=187 This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday Bernstein analyst Varun Govindaraj upgraded 3M Co (NYSE: MMM) from Underperform to Market Perform, raising the price target from $145 to $171. 3M shares closed at $167.52 on Thursday. This upgrade is part of a broader trend, as several companies received analyst upgrades, indicating a positive shift in market sentiment. https://openbell.ai/news/NKE:1790361845457 2026-09-25T18:44:05.457Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Perak--Malaysia---February-18--2018---Ni.jpg?width=250&height=187 This Nike Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday B of A Securities analyst Lorraine Hutchinson downgraded Nike Inc (NYSE: NKE) from Neutral to Underperform, reducing the price target from $47 to $30, while Nike's stock closed at $35.99 on Thursday. This downgrade is part of a broader trend, as analysts have also downgraded several other companies, including Comcast and Twilio, indicating a cautious outlook in the market. https://openbell.ai/news/SNX:1790361682887 2026-09-25T18:41:22.887Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Analyst-Works-On-Personal-Computer-Showi.jpg?width=250&height=187 TD Synnex Analysts Boost Their Forecasts After Q3 Results TD SYNNEX Corp (NYSE: SNX) reported a fiscal Q3 2026 adjusted EPS of $5.68, a 59% increase year-over-year, surpassing estimates of $4.70. Revenue rose 37.7% to $21.56 billion, exceeding the $18.91 billion forecast. For Q4, the company anticipates adjusted EPS between $5.65 and $6.15 and revenue of $21.8 billion to $22.6 billion, both above analyst expectations. Following the results, analysts from Morgan Stanley and UBS raised their price targets to $359 and $379, respectively, while shares increased by 1.1% to $262.39. https://openbell.ai/news/STEM:1790361599896 2026-09-25T18:39:59.896Z daily 0.9 https://cdn.brandfetch.io/STEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stem shares are trading higher after UBS upgraded the stock from Neutral to Buy rating and maintained the price target at $7. openbell Financial News https://openbell.ai/news/MRLN:1790361249763 2026-09-25T18:34:09.763Z daily 0.9 https://cdn.brandfetch.io/MRLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Merlin shares are trading higher after Canaccord Genuity initiated coverage on the stock with a Buy rating and announced a $7.5 price target. openbell Financial News https://openbell.ai/news/MBRX:1790361094451 2026-09-25T18:31:34.451Z daily 0.9 https://cdn.brandfetch.io/MBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Moleculin Biotech shares are trading higher after the company announced new preclinical data indicating that the antitumor activity of its lead drug candidate, Annamycin, in pancreatic cancer is partially mediated by CD8+ T cell cytotoxicity. openbell Financial News https://openbell.ai/news/DAL:1790361038115 2026-09-25T18:30:38.115Z daily 0.9 https://cdn.brandfetch.io/DAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of airline companies are trading higher as oil prices retreat after Iran's Foreign Minister confirmed that Iran has submitted to the U.S. a seven-day plan to reopen the Strait of Hormuz and start discussions on Iran's nuclear program. openbell Financial News https://openbell.ai/news/PYPL:1790360913595 2026-09-25T18:28:33.595Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/London--Uk---August-2021-Paypal-Finance-.jpg?width=250&height=187 Why Is PayPal Stock Surging on Friday? PayPal Holdings Inc. (NASDAQ: PYPL) stock surged 4.80% to $55.13 on Friday amid renewed acquisition rumors and a significant partnership in artificial intelligence. Reports indicate that a West Coast technology company is considering an all-stock takeover, although PayPal's board prefers an all-cash transaction. Additionally, Great Hill Capital's Chairman suggested that Meta Platforms Inc. could acquire PayPal for $90 billion, which would be accretive and enhance ad revenue capabilities. The stock is currently trading above its 20-day and 100-day simple moving averages, indicating a mixed technical outlook. https://openbell.ai/news/SPY:1790360773594 2026-09-25T18:26:13.594Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fed's Hammack Says Likely Underlying Inflation Is Above Target Federal Reserve official Hammack indicated that the underlying inflation rate is likely above the Fed's target level. This statement may influence market expectations regarding future monetary policy and interest rate adjustments. The comments come amidst ongoing discussions about inflationary pressures in the economy. https://openbell.ai/news/NVO:1790360631111 2026-09-25T18:23:51.111Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Novo-Nordisk.jpg?width=250&height=187 What's Going on With Novo Nordisk Stock on Friday? Novo Nordisk A/S outlined a strategic roadmap during its Capital Markets Day 2026, aiming for global expansion and plans to introduce over five multi-blockbuster medications by 2030, targeting 150 billion Danish kroner (approximately $23.06 billion) in risk-adjusted sales by 2035. The company is also considering mergers and acquisitions to enhance its pipeline, especially as it faces challenges with the patent expiration of semaglutide. Additionally, Novo Nordisk entered a licensing agreement with Nanexa AB, potentially worth up to 1.165 billion euros, to develop long-acting injectable formulations. As of Friday, Novo Nordisk shares were down 0.26% to $38.52. https://openbell.ai/news/PLTR:1790360015612 2026-09-25T18:13:35.612Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Peter-Thiel-Says-Popes-AI-Push-Could-Ben.jpg?width=250&height=187 Peter Thiel: Palantir Sales to US Corporations Accelerated 'Tremendously' As Europe Falls Behind in AI Palantir Technologies Inc. reported a 55% year-over-year increase in U.S. commercial revenue, reaching $159 million in Q2 2024, with the total U.S. customer count rising by 83%. Co-founder Peter Thiel highlighted the rapid acceleration of sales to U.S. corporations as they adapt to AI, contrasting this with Europe's slower adoption. He emphasized that Europe is significantly lagging behind in AI development, a sentiment echoed by IMF Managing Director Kristalina Georgieva. Palantir shares are currently trading at approximately $191.78, down 0.4%. https://openbell.ai/news/VRT:1790360011349 2026-09-25T18:13:31.349Z daily 0.9 https://cdn.brandfetch.io/VRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of data center infrastructure-related companies are trading higher amid multiple catalysts including optimism connected to demand for Meta's Muse AI agent and Akamai's seven-year, $11.6 billion cloud services agreement from Anthropic, both of which help underpin demand for physical compute space. openbell Financial News https://openbell.ai/news/KKR:1790359961299 2026-09-25T18:12:41.299Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Old-Books-On-A-Wooden-Shelf.jpg?width=250&height=187 Private Equity Is Pouring Money Into Publishing Again — Here’s Why In 2026, private equity and venture capital investments in the publishing industry surged to $918.8 million by September 22, more than double the $369.1 million recorded for all of 2025, according to S&P Global Market Intelligence. Despite a decrease in transaction count from 25 in 2025 to 20 in 2026, the industry remains attractive due to predictable cash flows and opportunities for consolidation. Notably, KKR & Co. acquired a 51% stake in Thomson Reuters' global print business for approximately $500 million, making Canada the largest market for publishing investment during this period. https://openbell.ai/news/ETHUSD:1790359378405 2026-09-25T18:02:58.405Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Two-Coins-Bitcoin-And-Ethereum-On-A-Dark.jpg?width=250&height=187 Bitcoin Is an 'Exit Asset'—Ethereum Is the New Rails Bet, Ex-BlackRock Exec Says Joseph Chalom, CEO of SharpLink, describes Bitcoin as an 'exit asset' and Ethereum as the foundation for new financial infrastructure. He estimates that approximately $4 trillion in financial services fees are at risk over the next decade due to the convergence of stablecoins, tokenized assets, decentralized finance (DeFi), and AI agents. SharpLink is actively managing a treasury of 900,000 ETH, providing equity holders with exposure to staking yields and capital appreciation. Chalom believes both Bitcoin and Ethereum have entered a new bull market. https://openbell.ai/news/VG:1790359254889 2026-09-25T18:00:54.889Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Stock-Market-Chart-stock-Market-Data-On-.jpg?width=250&height=187 Squeeze Watch: 10 Stocks With Over 33% Short Interest Ten stocks with market caps over $2 billion have more than 33% of their float sold short, with Venture Global Inc. leading at 80.47% short interest and a market cap of $32.19 billion. Other notable companies include Minimed Group Inc. at 47.64% and CleanSpark Inc. at 42.81%. Ondas Holdings Inc. is heavily traded, averaging 82.57 million shares daily, while SoundHound AI Inc. has 40.47% short interest. The list highlights potential candidates for short squeezes amid high trading volumes. https://openbell.ai/news/SLV:1790359110456 2026-09-25T17:58:30.456Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Silver.png?width=250&height=187 Why Deep Out Of The Money Silver Calls Look Attractive Now The article discusses the current attractiveness of deep out-of-the-money silver call options, particularly in light of the Federal Reserve's recent interest rate hike to 3.75%-4.00%. With 58% of silver demand tied to industrial use, the outlook for silver is mixed due to potential declines in demand from the solar sector. The Silver Institute forecasts a sixth consecutive annual silver deficit in 2026, with demand exceeding supply by 46.3 million ounces, suggesting that while industrial demand may soften, the ongoing supply deficit could support silver prices. https://openbell.ai/news/PRME:1790358981986 2026-09-25T17:56:21.986Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Doctor-Working-On-Virtual-Touch-Screen-P.jpg?width=250&height=187 Prime Medicine Gets FDA Green Light for Gene Editing Study Prime Medicine, Inc. (NASDAQ: PRME) received FDA clearance for its Investigational New Drug application for PM647, a gene editing therapy targeting Alpha-1 Antitrypsin Deficiency (AATD). The Phase 1/2 clinical trial will assess the safety and efficacy of PM647 in adult patients, starting with those exhibiting lung manifestations of AATD. Following the announcement, PRME shares declined by 6.19% to $2.88. https://openbell.ai/news/SPCX:1790358921221 2026-09-25T17:55:21.221Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/SpaceX-starships-in-launch-position-at-t.jpg?width=250&height=187 SpaceX 2X ETFs Slide Over 6% as Starship 14 Nears, $52.5M Insider Sale Adds to Volatility SpaceX's leveraged ETFs have experienced significant declines, with the Defiance Daily Target 2X Long SpaceX ETF down 6.5%, ProShares Ultra SpaceX down 6.6%, and Direxion Daily SpaceX Bull 2X down 6.7% this week. This downturn comes ahead of the anticipated Starship Flight 14 on September 28, which could further increase volatility. Additionally, SpaceX President Gwynne Shotwell sold 342,170 shares worth approximately $52.55 million, executed under a pre-arranged trading plan. Over the past three months, SPCX has declined about 2.7%, while the leveraged ETFs have seen losses between 20.6% and 21.3%. https://openbell.ai/news/AIFF:1790358782508 2026-09-25T17:53:02.508Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/An-Elderly-Person-With-Highlighted-Brain.jpg?width=250&height=187 Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD Care Firefly Neuroscience Inc. (NASDAQ: AIFF) has partnered with NeuroSigma, Inc. to enhance access to the Monarch eTNS System, a non-drug therapy for pediatric ADHD. This collaboration aims to integrate Firefly's AI-powered Evoke platform with NeuroSigma's device, which is FDA-cleared for children aged 7 to 12 not currently on ADHD medications. Following the announcement, Firefly's stock rose by 42.01% to $1.68. https://openbell.ai/news/CLSK:1790358491425 2026-09-25T17:48:11.425Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Cary--North-Carolina---August-12-2025-Cl.jpg?width=250&height=187 CleanSpark Raises Capital via Expensive Debt, Stock Falls CleanSpark, Inc. (NASDAQ: CLSK) announced the closing of a $2.276 billion offering of 7.875% senior secured notes due 2031, which has raised concerns among investors regarding the increased debt burden on its balance sheet. Following this announcement, CLSK's stock fell by 4.10% to $13.68, contrasting with gains in the broader market, including a 0.52% increase in the Nasdaq. The proceeds from the debt are intended to fund the development of its Sandersville facility, but the high interest rate adds significant pressure on the company's financials. https://openbell.ai/news/NKE:1790358130236 2026-09-25T17:42:10.236Z daily 0.9 https://cdn.brandfetch.io/NKE/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Converse Pauses Social Media Ads, Marketing After Racism Uproar' - Bloomberg News Converse, a subsidiary of Nike (NKE), has halted its social media advertising and marketing efforts following a backlash over allegations of racism. The decision comes in response to public outcry and aims to address the concerns raised by consumers. The company has not disclosed any financial implications or specific timelines for resuming its marketing activities. https://openbell.ai/news/CF:1790357527659 2026-09-25T17:32:07.659Z daily 0.9 https://cdn.brandfetch.io/CF/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of fertilizer companies are trading lower after Iran's Foreign Minister confirmed that Iran has submitted to the U.S. a seven-day plan to reopen the Strait of Hormuz and start discussions on Iran's nuclear program, which may lead to an export rebound from the region and pressure market prices. openbell Financial News https://openbell.ai/news/GOW:1790357476398 2026-09-25T17:31:16.398Z daily 0.9 https://cdn.brandfetch.io/GOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud GOWell Technology Completes Business Combination with Inflection Point Acquisition Corp. V, To Trade Under NASDAQ Ticker "GOW" GOWell Technology Limited has completed its business combination with Inflection Point Acquisition Corp. V, with the deal closing on September 25, 2026, after receiving shareholder approval on September 3, 2026. The new entity will operate as GOWell Energy Technology and will begin trading on NASDAQ under the ticker 'GOW' starting September 28, 2026. The business combination included a PIPE investment that raised approximately $70 million in gross proceeds to support growth initiatives and working capital. https://openbell.ai/news/META:1790357267830 2026-09-25T17:27:47.830Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jury Finds Meta Platforms Misled New Mexico Consumers In Cambridge Analytica Trial A jury has determined that Meta Platforms misled consumers in New Mexico during the Cambridge Analytica trial. This ruling may have implications for the company's reputation and legal standing. Further financial repercussions or stock price movements are not detailed in the article. https://openbell.ai/news/LNG:1790357155883 2026-09-25T17:25:55.883Z daily 0.9 https://cdn.brandfetch.io/LNG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of oil and gas related companies are trading lower after Iran's Foreign Minister confirmed that Iran has submitted to the U.S. a seven-day plan to reopen the Strait of Hormuz and start discussions on Iran's nuclear program. Also, companies exposed to U.S. natural gas markets have seen physical prices decline due to high production and inventory, lower LNG export volumes, and mild autumn weather in North America. openbell Financial News https://openbell.ai/news/CRWD:1790356889756 2026-09-25T17:21:29.756Z daily 0.9 https://cdn.brandfetch.io/CRWD/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'US Justice Department Closes Investigation of CrowdStrike Deals' - Bloomberg News The US Justice Department has closed its investigation into CrowdStrike's business deals, which had raised concerns regarding potential antitrust violations. This decision removes a regulatory hurdle for the cybersecurity firm, potentially allowing for smoother operations and growth. The closure of the investigation may positively impact CrowdStrike's stock performance, as it alleviates uncertainty surrounding the company's business practices. https://openbell.ai/news/RWT:1790356878562 2026-09-25T17:21:18.562Z daily 0.9 https://cdn.brandfetch.io/RWT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Redwood Trust 13D Filing Shows Amster Howard Reports 9% Stake In Co. As Of Sept. 18 Redwood Trust (RWT) has received a 13D filing indicating that Amster Howard has reported a 9% stake in the company as of September 18. This filing highlights a significant investment in Redwood Trust, potentially impacting its stock performance and market perception. https://openbell.ai/news/ACAD:1790356860245 2026-09-25T17:21:00.245Z daily 0.9 https://cdn.brandfetch.io/ACAD/w/400/h/400?c=1idopYfmtR7ZKg8QMud ACADIA Pharmaceuticals shares are trading lower after multiple analyst firms lowered their respective price targets on the stock. openbell Financial News https://openbell.ai/news/USO:1790356841886 2026-09-25T17:20:41.886Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oil is trading lower after Iran's Foreign Minister confirmed that Iran has submitted to the U.S. a seven-day plan to reopen the Strait of Hormuz and start discussions on Iran's nuclear program. openbell Financial News https://openbell.ai/news/NUTX:1790356572763 2026-09-25T17:16:12.763Z daily 0.9 https://cdn.brandfetch.io/NUTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nutex Health shares are trading higher after Freedom Capital Markets raised its price target on the stock from $280 to $306. openbell Financial News https://openbell.ai/news/MGM:1790356242892 2026-09-25T17:10:42.892Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Mgm-Grand-Hotel-And-Casino-In-Las-Vegas-.jpg?width=250&height=187 Stock of the Day: Is this the Bottom for MGM Resorts? MGM Resorts International (NYSE: MGM) experienced an 11% decline in stock price following Barry Diller's withdrawal of a proposal to acquire shares. The stock is currently considered oversold and near a support level of $32.85, which may present a buying opportunity for investors. A significant trading volume yesterday suggests potential seller capitulation, indicating that new buyers might drive the stock price upward if they enter the market. https://openbell.ai/news/HUM:1790356007471 2026-09-25T17:06:47.471Z daily 0.9 https://cdn.brandfetch.io/HUM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Humana shares are trading higher after Barclays upgraded its rating on the stock from Equal-Weight to Overweight and raised its price target from $407 to $515. openbell Financial News https://openbell.ai/news/MBRX:1790355960760 2026-09-25T17:06:00.760Z daily 0.9 https://cdn.brandfetch.io/MBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Moleculin Biotech Announces Preclinical Data Showing Annamycin Antitumor Activity In Pancreatic Cancer Is Immune-Mediated Moleculin Biotech, Inc. (NASDAQ: MBRX) announced preclinical data at the AACR Conference on Pancreatic Cancer indicating that its lead drug candidate, Annamycin, exhibits antitumor activity in pancreatic cancer that is partially mediated by CD8+ T cells. This suggests that Annamycin may not only directly kill cancer cells but also enhance immune response against tumors typically resistant to treatment. The findings could support potential combination therapies, particularly given the immune-modulating properties of the company's WP1066 program. https://openbell.ai/news/FFAI:1790355949945 2026-09-25T17:05:49.945Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Friday's Intraday Session On Friday, Faraday Future (NASDAQ: FFAI) saw its shares rise by 23.6% to $1.62, with a market cap of $8.0 million. Other notable gainers included Jowell Global (NASDAQ: JWEL) up 12.97% to $2.7, and Genius Sports (NYSE: GENI) which increased by 9.39% to $6.34, boasting a market cap of $1.5 billion. Conversely, America's Car-Mart (NASDAQ: CRMT) experienced a significant decline of 19.4% to $1.1, while Legacy Education (AMEX: LGCY) fell by 12.97% to $9.26 following its Q4 earnings report. https://openbell.ai/news/AIFF:1790355949687 2026-09-25T17:05:49.687Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Health Care Stocks Moving In Friday's Intraday Session On Friday, Firefly Neuroscience (NASDAQ: AIFF) saw a significant increase of 33.2% in its share price, reaching $1.58, with a market cap of $18.6 million. Other notable gainers included Apimeds Pharmaceuticals (AMEX: APUS), which rose 33.13% to $6.55, and Onconetix (NASDAQ: ONCO), up 22.95% to $1.12. Conversely, NexGel (NASDAQ: NXGL) experienced the largest decline, falling 35.9% to $0.17, with a market cap of $2.5 million. https://openbell.ai/news/INLF:1790355949447 2026-09-25T17:05:49.447Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Industrials Stocks Moving In Friday's Intraday Session On Friday, INLIF (NASDAQ: INLF) stock rose 59.32% to $4.70, with a market cap of $3.0 million, following the release of its H1 earnings. Other notable gainers included Masonglory (NASDAQ: MSGY), which surged 257.4% to $7.04, and Professional Diversity (NASDAQ: IPDN), which increased by 44.12% to $6.01. Conversely, ESS Tech (NYSE: GWH) saw a significant decline of 32.4% to $0.23, while VisionWave Holdings (NASDAQ: VWAV) shares fell by 15.89% to $4.87. https://openbell.ai/news/SHMD:1790355949150 2026-09-25T17:05:49.150Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Friday's Intraday Session On Friday, Schmid Group (NASDAQ: SHMD) saw a significant stock increase of 25.4%, reaching $4.54, with a market cap of $241.2 million. Other notable gainers included StableCoinX (NASDAQ: USDE) up 18.34% to $16.83 and MaxLinear (NASDAQ: MXL) up 11.54% to $95.16. Conversely, WidePoint (AMEX: WYY) experienced a sharp decline of 56.3%, falling to $4.84, while Trio-Tech Intl (NASDAQ: TRT) dropped 16.95% to $6.03 following its Q4 earnings report. https://openbell.ai/news/SLS:1790355824737 2026-09-25T17:03:44.737Z daily 0.9 https://cdn.brandfetch.io/SLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud SELLAS Life Sciences Announces Preclinical Data Demonstrating SLS009 Synergy And Activity In MYC-Amplified Pancreatic Cancer Models SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) announced preclinical data demonstrating that its CDK9 inhibitor SLS009 significantly increased apoptosis in MYC-amplified pancreatic cancer models, outperforming the RAS inhibitor daraxonrasib by more than six-fold. The combination of SLS009 with daraxonrasib resulted in an apoptosis rate of 36.5% and necrosis of 30.6%, suggesting a potential strategy to enhance RAS-directed therapy. Additionally, SLS009 showed synergistic activity when combined with BET inhibition, further supporting its efficacy against MYC-driven pancreatic cancer. These findings were presented at the AACR Conference on Pancreatic Cancer in San Diego. https://openbell.ai/news/QCOM:1790355678077 2026-09-25T17:01:18.077Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Qualcomm-Company-Office-In-Silicon-Valle.jpg?width=250&height=187 What Is Going on With Qualcomm Stock on Friday? Qualcomm Inc. (NASDAQ: QCOM) introduced new AI-focused Snapdragon chips at its Snapdragon Summit, including the Snapdragon 8 Elite Gen 6 and Snapdragon 8 Elite Extreme Gen 6, which enhance on-device AI capabilities. The company also extended its global patent agreement with Apple, effective April 1, 2027, while CEO Cristiano Amon discussed the potential for AI agents to transform smartphone functionality. As of Friday, Qualcomm's stock rose 5.69% to $205.32. https://openbell.ai/news/AGO:1790355474623 2026-09-25T16:57:54.623Z daily 0.9 https://cdn.brandfetch.io/AGO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Upgrades Assured Guaranty to Buy, Raises Price Target to $85 Roth Capital analyst Harry Fong has upgraded Assured Guaranty (NYSE: AGO) from Neutral to Buy. The price target for the stock has been raised from $80 to $85. https://openbell.ai/news/SKHY:1790355214828 2026-09-25T16:53:34.828Z daily 0.9 https://cdn.brandfetch.io/SKHY/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'SK Hynix's Solidigm Eyes 2027 IPO That Could Value It At $150B; Solidigm Held Pitch Meetings This Week With Banks For Roles In The IPO; Solidigm IPO Could Raise $15B In The U.S. Listing, Sources Say' - Reuters Exclusive SK Hynix's subsidiary Solidigm is planning an initial public offering (IPO) as early as next year, which could value the company at up to $150 billion and raise approximately $15 billion. Solidigm recently held pitch meetings with investment banks for roles in the IPO process, marking a significant step towards what could be the largest-ever US semiconductor listing. The IPO aims to capitalize on strong investor demand for companies associated with artificial intelligence infrastructure, although details remain in the early stages and may change based on market conditions. https://openbell.ai/news/USO:1790355186733 2026-09-25T16:53:06.733Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Senior Iranian Official Tells Reuters Strait Of Hormuz Will Remain Closed, No Nuclear Talks With US Until Iran's Conditions Met; Iran Will Make No Nuclear Concessions A senior Iranian official stated that the Strait of Hormuz will remain closed and that there will be no nuclear talks with the United States until Iran's conditions are met. The official emphasized that Iran will not make any concessions regarding its nuclear program. This announcement may have implications for oil markets and geopolitical stability in the region. https://openbell.ai/news/PETS:1790355061750 2026-09-25T16:51:01.750Z daily 0.9 https://cdn.brandfetch.io/PETS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4 Morgan Stanley analyst Erin Wright has maintained an Underweight rating on PetMed Express (NASDAQ: PETS) and has reduced the price target from $2.15 to $1.40. https://openbell.ai/news/AKAM:1790354929884 2026-09-25T16:48:49.884Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Konskie--Poland---December-08--2024-Akam.jpg?width=250&height=187 Akamai Jumps on Anthropic Deal, 30-Year Yields Top 5.5%: Stock Market Today (CORRECTED) Akamai Technologies Inc. experienced a significant intraday surge of up to 15% following its announcement of an $11.6 billion, seven-year cloud-infrastructure deal with Anthropic. Despite the initial spike, shares moderated as investors considered the $5.5 billion in capital expenditures Akamai will incur before realizing revenue from the deal. The broader market saw mixed performance, with the S&P 500 and Dow Jones Industrial Average posting slight gains, while the Nasdaq 100 declined by 0.1%. https://openbell.ai/news/IMCC:1790354897526 2026-09-25T16:48:17.526Z daily 0.9 https://cdn.brandfetch.io/IMCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud IM Cannabis shares are trading lower after the company announced a registered direct offering of 655,000 shares at $2.00 per share, raising about $1.3 million. openbell Financial News https://openbell.ai/news/MFG:1790354745079 2026-09-25T16:45:45.079Z daily 0.9 https://cdn.brandfetch.io/MFG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-listed Japanese banking companies are trading higher after Japanese 10-year government bond yields rose to a 30-year high, raising expectations of additional interest rate hikes that would boost bank lending margins. openbell Financial News https://openbell.ai/news/NVDA:1790354602969 2026-09-25T16:43:22.969Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/NVDA-logo-against-the-background-of-a-bu.jpg?width=250&height=187 Nvidia GPU Demand Is So Extreme, Even Bad Cloud Infrastructure Is Selling, SemiAnalysis Says NVIDIA Corp. (NASDAQ: NVDA) is experiencing extreme demand for its GPUs, with even poorly performing cloud providers able to sell their services at high margins. A report from SemiAnalysis noted that customers are willing to pay steep premiums for immediate access to compute resources, reflecting a significant supply-demand imbalance in the market. NVIDIA's Data Center revenue reached $89 billion last quarter, marking a 117% year-over-year increase, as AI demand continues to accelerate. https://openbell.ai/news/TWLO:1790354514572 2026-09-25T16:41:54.572Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Portland--Or--Usa---Apr-14--2020-The-Twi.jpg?width=250&height=187 Twilio Stock Drops After HSBC Downgrade to Reduce Twilio Inc. (NYSE: TWLO) shares fell 6.77% to $279.36 following HSBC's downgrade of the stock from Hold to Reduce, citing overvaluation linked to the recent hype surrounding Meta's Muse AI agent. HSBC analyst Sameer Lam maintained a price target of $211, arguing that Twilio's role in the AI space may be narrower than investors expect. Despite this downgrade, the overall consensus among Wall Street analysts remains bullish, with an average target of $254.59, and some firms, like TD Cowen, have raised their targets to as high as $300.